{"SPADE_UN_00961": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2004/0019181 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2004_0019181_A1", "Patent Type": "Patent Application", "Publication Date": "2004-1-29", "Family Info": "CA2230160A1,DE69637731D1,EP0846128A2,EP0846128B1,US6191254,US7390873,WO1997008199A2,WO1997008199A3", "Patent Title": "Antimicrobial cationic peptides.", "Abstract": "A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."}, {"Patent No": "US 6835536 B2", "Patent Link": "http://www.lens.org/lens/patent/US_6835536_B2", "Patent Type": "Granted Patent", "Publication Date": "2004-12-28", "Family Info": "US4510132,US6503881,US6538106,EP590070,WO9112815,WO0000214,WO0071175", "Patent Title": "Antimicrobial Cationic Peptides And Formulations Thereof", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganismcaused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}], "Sequence Information": {"SPADE ID": "SPADE_UN_00961", "Sequence": "ILKKWPWWAWRRK", "Sequence Length": 13, "Peptide Name": "Sequence 31 from Patent US 20040019181", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "WKR", "Absent Amino Acids": "CDEFGHMNOQSTUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 5, "Negative Residues": 0, "Mass": 1854.25, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": -1.22, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05585", "Similarity": 1.0, "Sequence": "MGAVIKVGAKVIGWGAASGAGLYGLEKILKK"}, {"SPADE_ID": "SPADE_N_10804", "Similarity": 1.0, "Sequence": "KFGKAFVKILKK"}, {"SPADE_ID": "SPADE_N_12471", "Similarity": 1.0, "Sequence": "LKKAKKFGKAFVKILKK"}]}}}